246 related articles for article (PubMed ID: 32070031)
1. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.
Geldenhuys WJ; Talasila PK; Sadana P
Bioorg Med Chem Lett; 2012 Sep; 22(17):5675-8. PubMed ID: 22858098
[TBL] [Abstract][Full Text] [Related]
3. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
4. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
[TBL] [Abstract][Full Text] [Related]
5. Unlocking SGK1 inhibitor potential of bis-[1-N,7-N, pyrazolo tetraethoxyphthalimido{-4-(3,5-Dimethyl-4-(spiro-3-methylpyazolo)-1,7-dihydro-1H-dipyrazolo[3,4-b;4',3'-e]pyridin-8-yl)}]p-disubstituted phenyl compounds: a computational study.
Verma AK; Ahmed SF; Hossain MS; Bhojiya AA; Upadhyay SK; Srivastava AK; Singh N; Harina H; Rahaman MM; Bahadur NM
J Biomol Struct Dyn; 2022; 40(24):13412-13431. PubMed ID: 34696688
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation.
Zhang H; Shen C; Zhang HR; Qi HZ; Hu ML; Luo QQ
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955763
[TBL] [Abstract][Full Text] [Related]
7. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
[TBL] [Abstract][Full Text] [Related]
8. Computational insights into the active structure of SGK1 and its implication for ligand design.
Akhoon BA; Gandhi NS; Pandey R
Biochimie; 2019 Oct; 165():57-66. PubMed ID: 31302161
[TBL] [Abstract][Full Text] [Related]
9. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
[TBL] [Abstract][Full Text] [Related]
10. Identification and Kinetic Characterization of Serum- and Glucocorticoid-Regulated Kinase Inhibitors Using a Fluorescence Polarization-Based Assay.
Kim J; Kim D; Jung H; Lee J; Hong VS
SLAS Discov; 2021 Jun; 26(5):655-662. PubMed ID: 33783250
[TBL] [Abstract][Full Text] [Related]
11. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
[TBL] [Abstract][Full Text] [Related]
12. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy.
Jairajpuri DS; Mohammad T; Adhikari K; Gupta P; Hasan GM; Alajmi MF; Rehman MT; Hussain A; Hassan MI
ACS Omega; 2020 Jun; 5(24):14720-14729. PubMed ID: 32596609
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.
Hammond M; Washburn DG; Hoang HT; Manns S; Frazee JS; Nakamura H; Patterson JR; Trizna W; Wu C; Azzarano LM; Nagilla R; Nord M; Trejo R; Head MS; Zhao B; Smallwood AM; Hightower K; Laping NJ; Schnackenberg CG; Thompson SK
Bioorg Med Chem Lett; 2009 Aug; 19(15):4441-5. PubMed ID: 19497745
[TBL] [Abstract][Full Text] [Related]
14. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.
Molecules; ; . PubMed ID: 35208955
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
